Professor Hilary Calvert receives Lifetime Achievement Award

Professor Hilary Calvert has received the Lifetime Achievement Award in the 2009 Excellence in Oncology Awards from the British Oncological Association. Professor Calvert, who has recently been appointed Director of Cancer Drug Discovery and Development at the UCL Cancer Institute, is internationally known among medical oncologists for his seminal work on chemotherapy and the development of the Calvert formula, which has benefited countless patients around the world. In his previous roles Professor Calvert worked as Clinical Director of the Northern Institute for Cancer Research; Professor of Medical Oncology at the University of Newcastle Upon Tyne; and Honorary Consultant in Medical Oncology at the Northern Centre for Cancer Care. The awards, which are run by the British Oncological Association (BOA) in conjunction with Pfizer Limited, recognise and reward best practice in oncology management, education and patient care across the UK. They are open to individuals or teams involved in oncology-related patient support and champion best practice in the treatment and care of cancer patients. Richard Sainsbury, chair of this year's judging panel and BOA president said: 'Hilary Calvert has had an outstanding career, making substantial advances in research and in anti-cancer drug development. His clinical commitment has led to innovative and lasting contributions that continue to benefit patients today.